Galmed Pharmaceuticals rebrands as EoCene, shifts Nasdaq ticker to EOCN Sept. 10 - GLMD News | RalliesGalmed Pharmaceuticals rebrands as EoCene, shifts Nasdaq ticker to EOCN Sept. 10
G
GLMD• Rebrand and ticker change
- Galmed Pharmaceuticals will rebrand as EoCene, shifting its Nasdaq Capital Market ticker to EOCN effective Sept. 10, 2026.
- Ordinary shares will keep trading on Nasdaq without interruption under the new symbol.
- Nasdaq minimum bid price compliance was regained, supporting the continued listing.
•
